Taevas
South KoreaPersonal Care & Beauty
Product Registration
Market Access for Product-Registration in South Korea
Navigating the complexities of global product registration requires a robust market access strategy. We empower life sciences companies to secure optimal market entry and reimbursement across diverse international healthcare systems, ensuring your innovat
Market
Global
Industry
Product-Registration
Regulator
Global Regulatory Bodies
Timeline
8-16 weeks (initial strategy)
Deliverables
Market Access Strategy, Value Dossier Framework, Pricing Recommendations
What We Deliver
6 Pillars of Market Access for Global Product Registration
Every engagement covers a structured set of pillars — each customised to your specific category, target segment, and strategic questions.
01
Global Regulatory Intelligence & Strategy
We provide in-depth analysis of diverse global regulatory landscapes, identifying critical pathways and requirements to integrate market access considerations from the earliest stages of product development.
Regulatory pathway mapping across key markets
Early market access integration into development plans
How It Works
How Our Global Market Access Process Works
A structured engagement — typically delivered in a few weeks.
Step 1 · Week 1-2
Discovery & Landscape Analysis
We begin with a deep dive into your product, therapeutic area, and target global markets, analyzing regulatory pathways, HTA requirements, and competitive landscapes.
Market Snapshot
Market Overview: Global Product Registration & Market Access
Rising Complexity of Global P&R
The increasing stringency of HTA requirements and diverse pricing policies across countries necessitate a sophisticated, region-specific market access approach for successful product registration.
Early Integration is Key
Integrating market access considerations from early clinical development phases significantly improves the likelihood of favorable reimbursement and reduces time-to-market in complex global environments.
Evidence Demands are Intensifying
Payers and health authorities globally demand robust real-world evidence and cost-effectiveness data beyond clinical trial results, making strategic evidence generation crucial for market entry.
What's Included
Deliverables
A structured, decision-ready package of deliverables.
Global Market Access Strategy Report
A comprehensive document outlining strategic recommendations for market entry, pricing, and reimbursement across your priority global markets.
Value Dossier Framework & Content Guidance
A structured framework for developing compelling value dossiers, tailored for diverse global payer audiences and HTA submissions.
Payer & Stakeholder Engagement Plan
A detailed roadmap for engaging key external stakeholders to build advocacy and facilitate favorable market access conditions.
Who This Is For
Use Cases
New Market Entry
Launching a Novel Therapy in Multiple Regions
A biotech firm developed a breakthrough oncology drug and needed to simultaneously register and secure reimbursement in North America, Europe, and key APAC markets, each with unique regulatory and HTA requirements.
Outcome
Taevas Life Sciences delivered a coordinated global market access strategy, enabling successful product launches and favorable reimbursement outcomes across all target regions.
Next Steps
Related Services
FAQ
Frequently Asked Questions
Get Started
Ready to Start Market Access for Your Product Registration in Global Markets?
Partner with Taevas Life Sciences to navigate the complexities of global market access and ensure your innovative therapies reach patients worldwide.
Access to Global Market Expertise
Streamlined Regulatory & Reimbursement Pathways
Maximized Product Value & Commercial Success
Reduced Time to Market & Patient Access